CKD classification based on estimated GFR over three years and subsequent cardiac and mortality outcomes: A cohort study

BMC Nephrology

Volumn 10, Issue 1, 2009, Pages

  Weiner, Daniel E ^a   Krassilnikova, Maria ^a   Tighiouart, Hocine ^a   Salem, Deeb N ^a   Levey, Andrew S ^a   Sarnak, Mark J ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DISEASE CLASSIFICATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; ATHEROSCLEROSIS; CHRONIC KIDNEY FAILURE; COMORBIDITY; INCIDENCE; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STROKE; SURVIVAL; SURVIVAL RATE; UNITED STATES;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BOSTON; COMORBIDITY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STROKE; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 70350004834     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-10-26     Document Type: Article

References (23)

1. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002 39 2 Suppl 1 1 266 11904577
2. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. AS Go GM Chertow D Fan CE McCulloch CY Hsu, N Engl J Med 2004 351 13 1296 305 10.1056/NEJMoa041031 15385656
3. Mortality risk stratification in chronic kidney disease: one size for all ages? AM O'Hare D Bertenthal KE Covinsky, et al. J Am Soc Nephrol 2006 17 3 846 53 10.1681/ASN.2005090986 16452492
4. In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression. BO Eriksen OC Ingebretsen, Kidney Int 2007 72 10 1242 8 10.1038/sj.ki.5002472 17687256
5. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. BF Culleton MG Larson PW Wilson JC Evans PS Parfrey D Levy, Kidney Int 1999 56 6 2214 9 10.1046/j.1523-1755.1999.00773.x 10594797
6. Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. AX Garg WF Clark RB Haynes AA House, Kidney Int 2002 61 4 1486 94 10.1046/j.1523-1755.2002.00270.x 11918756
7. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. P Muntner J He L Hamm C Loria PK Whelton, J Am Soc Nephrol 2002 13 3 745 53 11856780
8. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. DE Weiner S Tabatabai H Tighiouart, et al. Am J Kidney Dis 2006 48 3 392 401 10.1053/j.ajkd.2006.05.021 16931212
9. Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. RM Henry PJ Kostense G Bos, et al. Kidney Int 2002 62 4 1402 7 10.1111/j.1523-1755.2002.kid571.x 12234312
10. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. J Coresh BC Astor T Greene G Eknoyan AS Levey, Am J Kidney Dis 2003 41 1 12 10.1053/ajkd.2003.50007 12500213
11. Prevalence of chronic kidney disease in the United States. J Coresh E Selvin LA Stevens, et al. Jama 2007 298 17 2038 47 10.1001/jama.298.17.2038 17986697 (Pubitemid 350074801)
12. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. J Coresh BC Astor G McQuillan, et al. Am J Kidney Dis 2002 39 5 920 9 10.1053/ajkd.2002.32765 11979335
13. Rapid kidney function decline and mortality risk in older adults. DE Rifkin MG Shlipak R Katz, et al. Arch Intern Med 2008 168 20 2212 8 10.1001/archinte.168.20.2212 19001197
14. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989 129 4 687 702 2646917
15. The Cardiovascular Health Study: design and rationale. LP Fried NO Borhani P Enright et al. Ann Epidemiol 1991 1 3 263 76 1669507
16. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. DE Weiner H Tighiouart PC Stark et al. Am J Kidney Dis 2004 44 2 198 206 10.1053/j.ajkd.2004.04.024 15264177
17. Area socioeconomic status and progressive CKD: the Atherosclerosis Risk in Communities (ARIC) Study. SS Merkin J Coresh AV Roux HA Taylor NR Powe, Am J Kidney Dis 2005 46 2 203 213 10.1053/j.ajkd.2005.04.033 16112038
18. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. AS Levey J Coresh T Greene, et al. Ann Intern Med 2006 145 4 247 54 16908915
19. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. DE Weiner H Tighiouart PT Vlagopoulos, et al. J Am Soc Nephrol 2005 16 6 1803 10 10.1681/ASN.2004070597 15857925
20. A new equation to estimate glomerular filtration rate. AS Levey LA Stevens CH Schmid et al. Ann Intern Med 2009 150 9 604 12 19414839
21. Predictive power of sequential measures of albuminuria for progression to ESRD or death in Pima Indians with type 2 diabetes. ME Pavkov WC Knowler RL Hanson PH Bennett RG Nelson, Am J Kidney Dis 2008 51 5 759 66 10.1053/j.ajkd.2008.01.011 18436086
22. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. MJ Sarnak AS Levey AC Schoolwerth, et al. Circulation 2003 108 17 2154 69 10.1161/01.CIR.0000095676.90936.80 14581387
23. Current status and future perspectives for CKD testing. LA Stevens AS Levey, Am J Kidney Dis 2009 53 3 Suppl 3 17 26 10.1053/j.ajkd.2008.07.047 19231757